...
首页> 外文期刊>HPB: the official journal of the International Hepato Pancreato Biliary Association >Resection of colorectal liver metastases and extra-hepatic disease: a systematic review and proportional meta-analysis of survival outcomes
【24h】

Resection of colorectal liver metastases and extra-hepatic disease: a systematic review and proportional meta-analysis of survival outcomes

机译:结直肠癌肝转移和肝外疾病的切除:系统评价和生存结果的比例荟萃分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Colorectal cancer (CRC) accounts for 9.7% of all cancers with 1.4 million new cases diagnosed each year. 19-31% of CRC patients develop colorectal liver metastases (CRLM), and 23-38% develop extra-hepatic disease (EHD). The aim of this systematic review was to determine overall survival (OS) in patients resected for CRLM and known EHD.
机译:背景:大肠癌(CRC)占所有癌症的9.7%,每年诊断出140万新病例。 19-31%的CRC患者出现大肠肝转移(CRLM),而23-38%的患者发生肝外疾病(EHD)。这项系统评价的目的是确定接受CRLM和已知EHD切除的患者的总生存期(OS)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号